Although various hypotheses about the pathogenesis of AD have been proposed, such as the amyloid cascade hypothesis, tau protein hypothesis, inflammation hypothesis, and cholinergic injury theory, the pathogenesis of AD has not been fully elucidated, which limits the therapeutic effect of clinical trial drugs [6]. Here, MAPT is linked to Alzheimer disease.